CASY Casey's General Stores, Inc.
Casey's General Stores, Inc., together with its subsidiaries, operates convenience stores under the Casey's and Casey's General Store names in the United States. Its stores offer pizza, donuts, hot breakfast items, and sandwiches; and beverages, tobacco and nicotine products. The company's stores also provide soft drinks, energy, water, sports drinks, juices, coffee, and tea and dairy products; beer, wine, and spirits; snacks, candy, packaged bakery, and other food items; ice, ice cream, meals, and appetizers; health and beauty aids, automotive products, electronic accessories, and housewares. In addition, its stores offer motor fuel for sale on a self-service basis; gasoline and diesel fuel; and ATM, lotto/lottery, and prepaid cards, as well as car wash services. The company also operates distribution centers. Casey's General Stores, Inc. was founded in 1959 and is headquartered in Ankeny, Iowa.…
Industry Peers
Specialty RetailKey Statistics
About Casey's General Stores (NASDAQ: CASY)
›
Casey's General Stores (NASDAQ: CASY) is listed on Nasdaq, where its shares trade in USD. It belongs to the Specialty Retail industry, part of the Consumer Cyclical sector, and reports about 23,490 employees.
The shares were at 685.50 USD on 19 November 2026, up 31.3% over 52 weeks. Its 52-week range is 519.46 USD to 927.85 USD: the price is 26.1% below the high and 32.0% above the low.
At a market capitalisation of 25.34B USD, it trades at 33.0 times trailing earnings and 29.1 times forward earnings. The median trailing P/E of its 20 largest Specialty Retail peers is 16.6, a premium of 99% for CASY. It pays a dividend yielding 0.37% (it pays out 11% of its earnings), against a median of 2.88% among the dividend payers in that peer group.
Casey's General Stores reports return on equity of 18.1%, an operating margin of 5.9% and revenue up 24.3% year over year.
Its debt exceeds its cash by 2.36B USD, a debt-to-equity ratio of 0.74. Its Piotroski F-score is 9 out of 9, a strong reading of its financial health. 20 analysts cover the stock, with an average rating of Buy; their mean price target of 789.25 USD is 15.1% above the current price. The next earnings report is expected on 8 December 2026.